Report Publisher
Post-Covid-19 Epidemic Era, Non-Invasive Prenatal Testing (NIPT) Industry Development Trend Analysis Report 2023
MARKET COMPETITIVE LANDSCAPE:
Major players in this market include Illumina, Thermo Fisher, Roche, HYK Gene, Berry Genomics, and etc.
---The combined market share of the Top 3 players in the global Non-Invasive Prenatal Testing (NIPT) market is about 83.37%.
REGION SHARE:
The report covers the market size information of major Regions/Countries around the world, including NA/United States, EU/Germany, APAC/China, LA/SA, MEA and etc.
---In the geographical distribution of Non-Invasive Prenatal Testing (NIPT) market in 2022, the North America has the largest market size and its market share is about 46.48%, followed by Europe and its market share is about 26.82%.
SEGMENT OVERVIEW:
This report conducts segment analysis on type and application level. Type segment includes Consumables & Reagents, Instruments, etc. Application segment includes Hospital, Clinics, etc.
---Consumables & Reagents contributes approximately 72.56% share to the market in 2022.
---Research Laboratories contributes approximately 61.76% share to the market in 2022.
The cumulative impact of COVID-19, Russia-Ukraine conflict, and high inflation is expected to have a significant long-term impact on the global Non-Invasive Prenatal Testing (NIPT) markets. Ongoing research considers changes in consumer behavior, supply chain disruptions, and government intervention caused by the pandemic. Likewise, the report considers the ongoing political and economic uncertainty in Eastern Europe caused by the Russia-Ukraine conflict and its potential impact on the supply-demand balance, pressure on pricing variables, and import, export, and trade. In addition, the report discusses the impact of high inflation on the global economy and details fiscal policies to measure and reduce its impact on demand, supply, cash flows, and currency exchange.
Market Statistics:
Reports provide market sizes and forecasts for multiple major currencies (USD, EUR, JPY, GBP, CNY, etc.); multi-currency support helps organizational leaders make informed decisions. This report takes 2018-2021 as the historical year, 2022 as the base year, 2023 as the semi-forecast year, and 2024-2029 as the full forecast year.
Market Share Analysis:
Market share analysis provides deep insights into the current status of vendors in a particular market space. By comparing suppliers” contributions to total revenue, customer base, and other key metrics, we can give companies a better understanding of their performance and the challenges they face as they compete for market share. The analysis also sheds light on the competitiveness of any given sector in terms of accumulation, diversification of strengths, and consolidation characteristics during the base year studied.
The report provides insights on the following metrics:
Market Penetration: Provides comprehensive information on the market offered by key players
Market Diversification: Provides detailed information on new product launches, greenfield regions, recent developments and investments
Market Trends: A Big Picture of the Cumulative Impact of COVID-19, Russia-Ukraine Conflict, and High Inflation
Competitive assessment and intelligence: Provides an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape and manufacturing capabilities of leading players
Product Development & Innovation: Provides intelligent insights into future technologies, R&D activities, and breakthrough product developments
Market Segmentation: Segment by Type, Application, and Region to provide detailed insights into market information.
Increasing Adoption: NIPT has gained popularity due to its accuracy and non-invasive nature compared to traditional invasive prenatal diagnostic tests such as amniocentesis or chorionic villus sampling (CVS). The wider availability and decreasing costs of NIPT have contributed to its increased adoption.
Expansion of Test Offerings: Initially, NIPT was primarily used to detect common chromosomal abnormalities such as Down syndrome (trisomy 21), Edwards syndrome (trisomy 18), and Patau syndrome (trisomy 13). However, the market has expanded to include additional tests for microdeletions, sex chromosome aneuploidies, and single gene disorders. This expansion has further fueled the growth of the NIPT market.
Advancements in Technology: Continuous advancements in sequencing technologies, such as next-generation sequencing (NGS), have improved the accuracy
Growing Maternal Age: The trend of delayed childbirth in many countries has resulted in a higher proportion of pregnancies in older women. Advanced maternal age increases the risk of chromosomal abnormalities, leading to a greater demand for prenatal testing. NIPT offers a safer alternative to invasive procedures for older women, contributing to its market growth.
Increasing Focus on Genetic Counselling: Genetic counselling plays a crucial role in the interpretation and communication of NIPT results to expectant parents. With the wider adoption of NIPT, there has been a greater emphasis on providing comprehensive genetic counselling services to support informed decision-making and address patient concerns.
Highlights-Regions
North America
United States
Canada
China
Asia Pacific (Excluding China)
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Nordic
Latin America
Brazil
Argentina
Mexico
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
Player list
Illumina
Thermo Fisher
Roche
HYK Gene
Berry Genomics
MGI Tech Co., Ltd
CapitalBio
Beckman Coulter
Others
Types list
Consumables & Reagents
Instruments
Application list
Hospital
Clinics
Research Laboratories
Contact US Anytime
- Tel: +86 195 30455980
- Email: reports@arstaresearch.com
Find More
Post-Covid-19 Epidemic Era, Non-Invasive Prenatal Testing (NIPT) Industry Development Trend Analysis Report 2023
Get a FREE sample
Have Requests? Need Customization? Our Research Team Will Help to Maximize Your "Interest Scope and Content Customization" into Our Analysis Report.
Custom Research
